JUN 15, 2016 12:14 PM PDT

Liposome capsules improve phage therapy

WRITTEN BY: Kerry Evans
2 5 558
Researchers devised a method to improve oral bacteriophage therapy.

The group, made up of investigators from the Autonomous University of Barcelona and the Catalan Institute for Nanoscience and Nanotechnology, encapsulated bacteriophages within liposomes. The liposomes make the phages more resistant to stomach acid and increase the amount of time they spend in the intestinal tract.
 
Bacteriophages (red) target and kill bacteria (blue).

These researchers already demonstrated that oral phage therapy is effective against Salmonella infection in chickens. However, they needed some way to keep the phages from being destroyed by the chicken’s stomach acid and to increase retention time in the intestines.

Enter liposome nanoencapsulation. The capsules have an average diameter of 320 nm and are positively charged. Conveniently, this technique can also be applied to bacteriophages of any shape and size.

The group first showed that encapsulation could protect the phages from stomach acid. When exposed to simulated gastric fluid with a pH of 2.8, the number of “viable” nonencapsulated phages decreased by as much as 7.8 log units. However, the number of encapsulated phages only decreased by around 5.4 log units.

Next, they tested whether encapsulation increased the retention time of phages in the intestinal tract. Sure enough, 38.1% of chickens retained the encapsulated phages in their ceca after 72 hours compared to only 9.5% of chickens that were given nonencapsulated phages.

Finally, they needed to know whether the encapsulated phages could effectively kill Salmonella in the chickens. They tested this by infecting broiler chickens with Salmonella and treating them orally with nonencapsulated or encapsulated phages. Both nonencapsulated and encapsulated phages decreased the Salmonella concentration in the cecum within the first 6 days after infection. However, from days 8 to 15, the encapsulated phages decreased the Salmonella concentration to a much greater degree than the nonencapsulated phages.

Does this mean phage therapy is one step closer to becoming a mainstream antibacterial therapy? Guess we’ll wait and see.

Sources: Applied and Environmental Microbiology, AlphaGalileo
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
MAY 19, 2018
Microbiology
MAY 19, 2018
Yogurt may Help Reduce Inflammation
While inflammation is an important part of the response to injury or illness, chronic inflammation has been implicated as a common factor in many diseases.
JUL 04, 2018
Drug Discovery
JUL 04, 2018
Increased Dose of Drug 'Rifampin' Effective in Eliminating Tuberculosis Bacterium
According to a randomized controlled trial, a TB drug by the name ‘Rifampin’ was seen to effectively kill TB bacteria in sputum cultures when a
JUL 11, 2018
Microbiology
JUL 11, 2018
New Insight Into Bacterial Pathogenicity
Scientists have learned how some pathogenic bacteria stick to cells in the intestine, which gets their infection started.
AUG 03, 2018
Microbiology
AUG 03, 2018
Dog Lick Leads to Limb Amputation
The CDC says don't give your dog up; this is thought to be a very rare case.
AUG 06, 2018
Microbiology
AUG 06, 2018
How Undetected Viral Infections Impact our Health
It seems that when people are infected with CMV but don't have any obvious symptoms, there may still be effects.
AUG 13, 2018
Microbiology
AUG 13, 2018
Insight Into the Origins of Junk DNA - From Koalas
The human genome isn't only genes. There's also long, repetitive sequences with an unknown function and origin.
Loading Comments...